Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 19, 2025, OptiNose (OPTN) has a market cap of $92.868 million USD. According to our data, OptiNose is ranked No.7647 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 19, 2025 | $92.87 M |
38.26%
|
| Dec 31, 2024 | $67.17 M |
-65.48%
|
| Dec 29, 2023 | $0.19 B |
-30.27%
|
| Dec 30, 2022 | $0.28 B |
14.20%
|
| Dec 31, 2021 | $0.24 B |
-60.87%
|
| Dec 31, 2020 | $0.62 B |
-55.10%
|
| Dec 31, 2019 | $1.39 B |
48.71%
|
| Dec 31, 2018 | $0.94 B |
-67.20%
|
| Dec 29, 2017 | $2.85 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 GlaxoSmithKline
GSK
|
$72.79 B |
-0.000 M
|
UK
|
 Sanofi
SNY
|
$124.64 B |
0.327 B
|
France
|
 Teva Pharmaceutical Industries
TEVA
|
$15.66 B |
0.000 M
|
Israel
|
 Pfizer
PFE
|
$125.57 B |
0.001 M
|
USA
|
 Novartis
NVS
|
$219.89 B |
0.932 B
|
Switzerland
|
 AstraZeneca
AZN
|
$210.29 B |
0.735 B
|
UK
|
 Merck
MRK
|
$196.28 B |
0.008 M
|
USA
|
 Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
USA
|
 Amgen
AMGN
|
$149.09 B |
0.124 B
|
USA
|
 Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
USA
|
 AbbVie
ABBV
|
$306.02 B |
0.008 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
USA
|
 Biogen
BIIB
|
$17.36 B |
-0.001 M
|
USA
|
| Market Cap | = | OPTN Stock Price | * | OPTN Shares Outstanding |
| = | $9.17 | * | 10.13 M | |
| = | $92.87 M |